Global Polyethylene Glycol Market Report to 2030 – Size and Share Analysis by Form, Grade and Application – ResearchAndMarkets.com
June 27, 2022DUBLIN–(BUSINESS WIRE)–The “Polyethylene Glycol Market Size and Share Analysis by Form, Grade, Application – Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
This report was worth $4,534.8 million, which will increase at a 4.8% CAGR from 2021 to 2030, to reach $6,909.6 million.
Company Profiles
- Akzo Nobel N.V.
- BASF SE
- The Dow Chemical Company
- Liaoning Oxiranchem Inc.
- India Glycols Ltd.
- Clariant AG
- INEOS Group Holdings S.A.
- Huntsman Corporation
- Jiangsu Haian Petroleum Chemical Factory
- Croda International Plc
The growing consumption of polyethylene glycol (PEG) as a specialty solvent and surface-active agent in shampoos, creams & lotions, toothpastes, conditioners, deodorants, lipsticks, soaps, bath oils, and detergents is the key factor driving the market.
The APAC polyethylene glycol market has seen significant expansion in recent decades because of the rising demand for water-based paints, coatings, and inks in the construction sector; therefore, it currently has the largest share. Furthermore, the rise of the paper industry in India and China is predicted to enhance the requirement for the chemical, which is used as a color stabilizer in ceramics and paper.
Additionally, the hydraulic fracturing technology has expanded the production of unconventional resources, including shale gas and tight oil, thus improving the access to the petrochemicals used in PEG and open up market opportunities.
PEG 400 Holds Largest Share in Market
PEG 400 holds the largest share in the polyethylene glycol market, and it will grow at a 5% CAGR in the coming years. This is mainly because this variant has a low molecular weight and not as toxic. It is also hydrophilic, which means it is ideal for boosting the solubility and bioavailability of drugs that are not adequately water-soluble.
Medical Sector Offers Largest Application Area for PEG
In 2021, the medical category held the largest share in the market. PEG is used as a solvent, dispensing agent, and delivery liquid for pharmaceuticals and ointments, as well as a tablet filler and suppository base in ophthalmic solutions and for curing constipation. Furthermore, the use of PEG, rather than monoethylene glycol, in the pharmaceutical sector is expected to have a favorable impact on the market.
North America Holds Significant Share
North America holds around 30% revenue share of the polyethylene glycol market, owing to the high production of crude oil. As per the U.S. Energy Information Administration, the present per-day production of crude oil in the country is approximately 11 million barrels. PEG usage is also being driven by the substantial expansion of the cosmetics and personal care sectors in the U.S. and Canada. Customers’ rising requirement for multifunctional personal care products and the increasing employed population are driving growth in the cosmetics and personal care industry in the continent.
Key Topics Covered:
Chapter 1. Research Background
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
5.1 Personal Care and Pharmaceutical Industry
5.1.1 Global Pharmaceutical Market Size
5.2 Global Specialty Chemicals Market
Chapter 6. Definition of Market Segments
6.1 By Form
6.1.1 Opaque Liquid
6.1.2 White Wax Solid
6.1.3 Flake/Powder
6.2 By Grade
6.3 By Application
Chapter 7. Industry Outlook
7.1 Market Dynamics
7.1.1 Trends
7.1.1.1 Technological advances to manufacture PEG
7.1.1.2 Increasing demand for bio-based PEG
7.1.2 Drivers
7.1.2.1 Growing demand for PEG in drugs and medical devices
7.1.2.2 Rising application in skin and personal care products
7.1.2.3 Proliferating construction industry
7.1.3 Impact Analysis of Drivers on Market Forecast
7.1.4 Restraints
7.1.4.1 Increasing preference for alternatives
7.1.4.2 Side-effects of drugs containing PEG
7.1.5 Impact Analysis of Restraints on Market Forecast
7.2 Impact of COVID-19
7.3 Value Chain Analysis
7.4 Porter’s Five Forces Analysis
7.4.1 Bargaining Power of Buyers
7.4.2 Bargaining Power of Suppliers
7.4.3 Intensity of Rivalry
7.4.4 Threat of New Entrants
7.4.5 Threat of Substitutes
Chapter 8. Policy and Regulatory Landscape
Chapter 9. Global Market Size and Forecast
Chapter 10. North America Market Size and Forecast
Chapter 11. Europe Market Size and Forecast
Chapter 12. APAC Market Size and Forecast
Chapter 13. LATAM Market Size and Forecast
Chapter 14. MEA Market Size and Forecast
Chapter 15. U.S. Market Size and Forecast
Chapter 16. Canada Market Size and Forecast
Chapter 17. Germany Market Size and Forecast
Chapter 18. France Market Size and Forecast
Chapter 19. U.K. Market Size and Forecast
Chapter 20. Italy Market Size and Forecast
Chapter 21. Spain Market Size and Forecast
Chapter 22. China Market Size and Forecast
Chapter 23. Japan Market Size and Forecast
Chapter 24. India Market Size and Forecast
Chapter 25. Australia Market Size and Forecast
Chapter 26. South Korea Market Size and Forecast
Chapter 27. Brazil Market Size and Forecast
Chapter 28. Mexico Market Size and Forecast
Chapter 29. Saudi Arabia Market Size and Forecast
Chapter 30. South Africa Market Size and Forecast
Chapter 31. Competitive Landscape
Chapter 32. Company Profiles
Chapter 33. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/6e7xnr.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900